Updated hourlyHourly refreshTue, Sep 22, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / September 14, 2026 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE:HIMS), if they purchased or otherwise acquired the Company's securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for ..
Sep 14 · 22:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 14, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sep 14 · 22:02·PR-Inside
Finance · Healthcare
COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to repurchase up to $400 million of the Company’s ordinary shares (the Share Repurchase Program).
Sep 14 · 22:00·GlobeNewswire
Healthcare
(PR-inside.com) DORADO, PR / ACCESS Newswire / September 14, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.3 million and $7.3 million, respectively, representing increases of approximately $0.4 million and $0.5 million compared to the same periods last year. For the three and nine months ended July 31, 2026, the Company reported a net loss of $14 thousand and net income of approximately $252 thousand, respectively, representing improvements of approximately $190 thousand and ..
Sep 14 · 21:20·PR-Inside
Healthcare
At Dreamforce 2026, ReDEFY, a Salesforce consulting partner, arrives having already built Environmental Health solutions for California county governments ahead of the state's CERS NextGen deadline. HERNDON, Va., Sept. 14, 2026 /PRNewswire/ -- With Dreamforce 2026 opening next week in San...
Sep 14 · 20:59·mlpr-prnewswire-wire
Finance · AI
Veea and NovaGen announce a potential merger and an edge AI-powered health platform, with a US$10 million investment commitment from GeoNova Capital.
Sep 14 · 20:42·GlobeNewswire
Healthcare
Letter warns proposed payment changes could undermine patient access and accelerate practice consolidation WASHINGTON, Sept. 14, 2026 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) issued its formal comment letter to the Centers for Medicare & Medicaid Services'...
Sep 14 · 20:30·PR Newswire
Finance · Healthcare
ATLANTA, Sept. 14, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that Brooke Pierce has been appointed President, Health, effective September 14, 2026.
Sep 14 · 20:30·GlobeNewswire
Finance · SaaS
Acquisition positions Veracyte to deliver powerful genomic insights from urine, tissue, and blood to help guide bladder cancer care across the patient journey Acquisition positions Veracyte to deliver powerful genomic insights from urine, tissue, and blood to help guide bladder cancer care across the patient journey
Sep 14 · 20:05·GlobeNewswire
Finance · Healthcare
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may...
Sep 14 · 20:00·mlpr-newsfile
Finance · Healthcare
(PR-inside.com) Prime Ledger engaged to structure an asset-specific, non-dilutive tokenized financing for CCX0722 - backed by intellectual property, with no issuance of Cosmos Health common stock Positions Cosmos Health among the earliest NASDAQ-listed healthcare companies pursuing tokenized IP-backed assets. CCX0722 is an ingestible, hydrogel-based medical device in development for weight management, using a mechanical mechanism with no systemic absorption Intellectual property owned outright, with patent applications advanced into the United States, Europe, Australia and Canada Addresses a global weight management market projected to reach $562.2 billion by 2033 (14.2% CAGR) - set against a broader tokenized real-world-asset market projected to reach ..
Sep 14 · 19:59·PR-Inside
SaaS · Healthcare
Endolumik, a medical device company developing fluorescence-guided surgical tools for minimally invasive procedures, today announced it has expanded the labeled use of its Endolumik Gastrointestinal Calibration Tube to include lower gastrointestinal tract surgical procedures, including colorectal surgery. Previously used in gastric and foregut procedures, the Endolumik device is designed to provide fluorescence-guided [PR.com]
Sep 14 · 19:33·PR.com